« Back to Record
Citation APA

Courcelle, R., Gaudry, S., Serck, N., Blonz, G., Lascarrou, J. B., Grimaldi, D., Aissaoui, N., Carbutti, G., D'Hondt, A., Higny, J., Horlait, G., Hraiech, S., Lefebvre, L., Lejeune, F. X., Ly, A., Piagnerelli, M., Sauneuf, B., Soumagne, T., Szychowiak, P., Textoris, J., Vandenbunder, B., & Vinsonneau, C. (2020). Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: A multicenter observational study. Critical care, 24(1), 446. doi:10.1186/s13054-020-03164-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/315372

Courcelle, R., Gaudry, S., Serck, N., Blonz, G., Lascarrou, J. B., Grimaldi, D., Aissaoui, N., Carbutti, G., D'Hondt, A., Higny, J., Horlait, G., Hraiech, S., Lefebvre, L., Lejeune, F. X., Ly, A., Piagnerelli, M., Sauneuf, B., Soumagne, T., Szychowiak, P., Textoris, J., Vandenbunder, B., & Vinsonneau, C. (2020). Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: A multicenter observational study. Critical care, 24(1), 446. doi:10.1186/s13054-020-03164-2